Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...

This shift follows the announcement of initial positive data from the Phase 1/2 clinical trial of PM359 in Chronic ...

Here we have not one but two Technics deals that stand out from the rest. One of these stereo amps is a Product of the Year ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate ...

JMP Securities reiterated its Market Outperform rating and $6.00 price target on Prime Medicine (NASDAQ:PRME) Wednesday following the announcement of the Eli Lilly (NYSE:LLY) and Verve ...

Jamnagar: India and the World Health Organization (WHO) are working in unison in the field of traditional medicine, with the ...

Federal Health Minister Syed Mustafa Kamal announced on Monday that every medicine sold in Pakistan will carry a barcode ...

The release follows India’s proposal on the subject, leading to the development of WHO’s first-ever roadmap for applying AI in traditional medicine.

Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.